Cogent Biosciences Inc. (COGT)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
8.08
0.71 (9.63%)
At close: Jan 15, 2025, 11:18 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Revenue | n/a | n/a | n/a | 7.87M | 22.50M | 9.73M | 8.36M | 6.36M | 2.99M |
Cost of Revenue | 3.59M | 5.88M | 147.00K | 25.74K | 43.71K | n/a | n/a | n/a | n/a |
Gross Profit | -3.59M | -5.88M | -147.00K | 7.85M | 22.46M | 9.73M | 8.36M | 6.36M | 2.99M |
Operating Income | -208.13M | -147.84M | -75.55M | -82.20M | -32.18M | -36.01M | -26.15M | -19.07M | -6.59M |
Interest Income | 13.08M | 3.99M | 467.00K | 144.00K | 267.00K | 1.15M | 386.00K | 265.00K | n/a |
Pretax Income | -192.41M | -140.24M | -72.27M | -74.81M | -31.83M | -34.53M | -25.49M | -18.12M | -6.59M |
Net Income | -192.41M | -132.64M | -71.81M | -66.45M | -30.27M | -34.53M | -25.49M | -18.12M | -6.59M |
Selling & General & Admin | 34.38M | 26.21M | 19.64M | 17.42M | 10.97M | 7.45M | 4.68M | 3.43M | 2.73M |
Research & Development | 170.17M | 121.63M | 55.91M | 72.65M | 43.71M | 38.28M | 29.83M | 21.99M | 6.85M |
Other Expenses | n/a | 3.61M | 2.81M | -246.00K | 78.00K | 320.00K | 274.00K | 681.00K | n/a |
Operating Expenses | 208.13M | 147.84M | 75.55M | 90.07M | 54.68M | 45.74M | 34.51M | 25.43M | 9.58M |
Interest Expense | n/a | 3.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 208.13M | 147.84M | 75.55M | 90.07M | 54.68M | 45.74M | 34.51M | 25.43M | 9.58M |
Income Tax | n/a | -7.60M | -467.00K | -8.36M | -1.56M | 1.47M | -386.00K | -265.00K | n/a |
Shares Outstanding (Basic) | 79.66M | 58.74M | 38.73M | 11.08M | 7.62M | 6.22M | 7.40M | 5.86M | 5.86M |
Shares Outstanding (Diluted) | 79.66M | 58.74M | 38.73M | 11.08M | 7.62M | 6.22M | 7.40M | 7.40M | 7.40M |
EPS (Basic) | -2.42 | -2.26 | -1.85 | -6 | -3.97 | -5.55 | -3.45 | -3.1 | -1.13 |
EPS (Diluted) | -2.42 | -2.26 | -1.85 | -6 | -3.97 | -5.55 | -3.45 | -2.45 | -0.89 |
EBITDA | -205.86M | -134.36M | -75.40M | -34.57M | -30.89M | -34.68M | -24.98M | -18.24M | -6.41M |
Depreciation & Amortization | 2.27M | 5.88M | 147.00K | 720.00K | 1.29M | 1.32M | 1.17M | 830.00K | 179.00K |